FI20021626A - Immunoassay reagent and method for the detection of hepatitis C virus (HCV) antibodies - Google Patents
Immunoassay reagent and method for the detection of hepatitis C virus (HCV) antibodies Download PDFInfo
- Publication number
- FI20021626A FI20021626A FI20021626A FI20021626A FI20021626A FI 20021626 A FI20021626 A FI 20021626A FI 20021626 A FI20021626 A FI 20021626A FI 20021626 A FI20021626 A FI 20021626A FI 20021626 A FI20021626 A FI 20021626A
- Authority
- FI
- Finland
- Prior art keywords
- hcv
- hepatitis
- antibodies
- virus
- detection
- Prior art date
Links
- 241000711549 Hepacivirus C Species 0.000 title 2
- 239000003153 chemical reaction reagent Substances 0.000 title 1
- 238000001514 detection method Methods 0.000 title 1
- 238000003018 immunoassay Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 108010067390 Viral Proteins Proteins 0.000 abstract 1
- 238000003556 assay Methods 0.000 abstract 1
- 210000002966 serum Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
- C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Abstract
We have discovered epitopes of the HCV viral proteins which are immunoreactive with immune serum. The epitopes are useful in immunodiagnostic assays and as immunogens.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US72248991A | 1991-06-24 | 1991-06-24 | |
US72248991 | 1991-06-24 | ||
PCT/US1992/005388 WO1993000365A2 (en) | 1991-06-24 | 1992-06-24 | Hepatitis c virus (hcv) polypeptides |
US9205388 | 1992-06-24 |
Publications (2)
Publication Number | Publication Date |
---|---|
FI20021626A true FI20021626A (en) | 2002-09-11 |
FI111645B FI111645B (en) | 2003-08-29 |
Family
ID=24902063
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI935808A FI110099B (en) | 1991-06-24 | 1993-12-22 | A method for producing hepatitis C virus (HCV) polypeptides |
FI20021626A FI111645B (en) | 1991-06-24 | 2002-09-11 | Reagents for immunoassay and method for detection of hepatitis C virus (HCV) antibodies |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI935808A FI110099B (en) | 1991-06-24 | 1993-12-22 | A method for producing hepatitis C virus (HCV) polypeptides |
Country Status (16)
Country | Link |
---|---|
US (2) | US6346375B1 (en) |
EP (1) | EP0591431B1 (en) |
JP (9) | JP3516681B2 (en) |
KR (1) | KR0185426B1 (en) |
AT (1) | ATE229543T1 (en) |
BG (1) | BG61843B1 (en) |
CA (1) | CA2110058C (en) |
DE (1) | DE69232871T2 (en) |
ES (1) | ES2188583T3 (en) |
FI (2) | FI110099B (en) |
HU (1) | HU227547B1 (en) |
NO (1) | NO309528B1 (en) |
RO (1) | RO117329B1 (en) |
RU (1) | RU2148587C1 (en) |
UA (1) | UA40572C2 (en) |
WO (1) | WO1993000365A2 (en) |
Families Citing this family (85)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5698390A (en) * | 1987-11-18 | 1997-12-16 | Chiron Corporation | Hepatitis C immunoassays |
US5712088A (en) * | 1987-11-18 | 1998-01-27 | Chiron Corporation | Methods for detecting Hepatitis C virus using polynucleotides specific for same |
US5714596A (en) * | 1987-11-18 | 1998-02-03 | Chiron Corporation | NANBV diagnostics: polynucleotides useful for screening for hepatitis C virus |
US6861212B1 (en) | 1987-11-18 | 2005-03-01 | Chiron Corporation | NANBV diagnostics and vaccines |
US6171782B1 (en) | 1987-11-18 | 2001-01-09 | Chiron Corporation | Antibody compositions to HCV and uses thereof |
US6027729A (en) * | 1989-04-20 | 2000-02-22 | Chiron Corporation | NANBV Diagnostics and vaccines |
US5582968A (en) * | 1990-02-16 | 1996-12-10 | United Biomedical, Inc. | Branched hybrid and cluster peptides effective in diagnosing and detecting non-A, non-B hepatitis |
US5639594A (en) * | 1990-02-16 | 1997-06-17 | United Biomedical, Inc. | Linear and branched peptides effective in diagnosing and detecting non-A, non-B hepatitis |
GB9204274D0 (en) * | 1992-02-28 | 1992-04-08 | Wellcome Found | Novel peptides |
US6709828B1 (en) | 1992-03-06 | 2004-03-23 | N.V. Innogenetics S.A. | Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing them and compositions containing them |
US6667387B1 (en) | 1996-09-30 | 2003-12-23 | N.V. Innogenetics S.A. | HCV core peptides |
DE4240980A1 (en) * | 1992-08-07 | 1994-02-10 | Boehringer Mannheim Gmbh | HCV peptide antigens and method for the determination of HCV |
US7255997B1 (en) | 1993-04-27 | 2007-08-14 | N.V. Innogenetics S.A. | Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents |
CA2662090A1 (en) | 1993-04-27 | 1994-11-10 | N.V. Innogenetics S.A. | New sequences of hepatitis c virus genotypes and their use as therapeutic and diagnostic agents |
GEP20012421B (en) | 1993-05-10 | 2001-04-25 | Chiron Corp | Method for Typing Hepatitis C Virus and Reagents for Use Therein |
DE69433160T2 (en) | 1993-05-12 | 2004-07-08 | Chiron Corp. (N.D.Ges.D. Staates Delaware), Emeryville | Preserved motif of the hepatitis C virus E2 / NS1 region |
US5514539A (en) * | 1993-06-29 | 1996-05-07 | The United States Of America As Represented By The Department Of Health And Human Services | Nucleotide and deduced amino acid sequences of the envelope 1 gene of 51 isolates of hepatitis C virus and the use of reagents derived from these sequences in diagnostic methods and vaccines |
US5639856A (en) * | 1993-09-13 | 1997-06-17 | The Regents Of The University Of California | Semaphorin gene family |
WO1995011918A1 (en) * | 1993-10-29 | 1995-05-04 | Srl, Inc. | Antigen peptide compound and immunoassay method |
DE69432475T2 (en) * | 1993-11-04 | 2004-03-04 | Innogenetics N.V. | OF HUMAN T CELLS IMMUNODOMINANT EPIROPEN OF THE VIRUS DER C-HEPATITIS |
US5709995A (en) * | 1994-03-17 | 1998-01-20 | The Scripps Research Institute | Hepatitis C virus-derived peptides capable of inducing cytotoxic T lymphocyte responses |
ES2176342T5 (en) * | 1994-10-21 | 2010-02-09 | Innogenetics N.V. | SEQUENCES OF GENOTYPE 7 OF THE HEPATITIS C VIRUS AND ITS USE AS PROFILACTIC, THERAPEUTIC AND DIAGNOSTIC AGENTS. |
GB2294690B (en) * | 1994-11-01 | 1998-10-28 | United Biomedical Inc | Peptides effective for diagnosis and detection of hepatitis C infection |
JPH08333390A (en) * | 1995-04-07 | 1996-12-17 | Hoechst Japan Ltd | Peptide and autoimmune disease-treating medicine comprising the same |
US6034064A (en) * | 1995-04-07 | 2000-03-07 | Hoechst Pharmaceuticals & Chemicals K.K. | Peptides and therapeutic agent for autoimmune diseases containing the same |
EP0829488A4 (en) * | 1995-04-28 | 1999-04-07 | Srl Inc | Antigen peptide compound and immunoassay method |
GB9513261D0 (en) * | 1995-06-29 | 1995-09-06 | Smithkline Beecham Biolog | Vaccines |
US6127116A (en) * | 1995-08-29 | 2000-10-03 | Washington University | Functional DNA clone for hepatitis C virus (HCV) and uses thereof |
US6514731B1 (en) | 1996-05-24 | 2003-02-04 | Chiron Corporation | Methods for the preparation of hepatitis C virus multiple copy epitope fusion antigens |
AU719929B2 (en) * | 1996-05-24 | 2000-05-18 | Grifols Worldwide Operations Limited | Multiple epitope fusion protein |
US7049428B1 (en) | 1998-03-04 | 2006-05-23 | Washington University | HCV variants |
US7338759B1 (en) | 1997-03-04 | 2008-03-04 | Washington University | HCV variants |
EP1021723B1 (en) | 1997-09-22 | 2008-12-10 | Novartis Vaccines and Diagnostics, Inc. | Buffers for stabilizing hcv antigens |
PT1071955E (en) * | 1998-04-17 | 2005-02-28 | Innogenetics Nv | IMMUNOLOGICAL DIAGNOSTIC IMPROVED ASSAYS USING REDUCING AGENTS |
US7052830B1 (en) * | 1998-06-09 | 2006-05-30 | Branch Andrea D | Hepatitis C virus peptides and uses thereof |
US7052696B2 (en) * | 1998-07-10 | 2006-05-30 | The United States Of America As Represented By The Department Of Health And Human Services | Antigenic epitopes and mosaic polypeptides of hepatitis C virus proteins |
US6191256B1 (en) * | 1998-11-20 | 2001-02-20 | Bayer Corporation | Recombinant factor VIII binding peptides |
EP1200109A4 (en) * | 1999-07-19 | 2005-06-15 | Epimmune Inc | Inducing cellular immune responses to hepatitis c virus using peptide and nucleic acid compositions |
CN1214244C (en) | 2000-06-15 | 2005-08-10 | 希龙公司 | HCV antigen/antibody combination assay |
EP2332574A1 (en) | 2000-08-17 | 2011-06-15 | Tripep Ab | HCV NS3/4A Sequences |
US6680059B2 (en) * | 2000-08-29 | 2004-01-20 | Tripep Ab | Vaccines containing ribavirin and methods of use thereof |
RU2286172C2 (en) | 2000-08-17 | 2006-10-27 | Трипеп Аб | Ribavirin-containing vaccines and methods for their application |
US7022830B2 (en) | 2000-08-17 | 2006-04-04 | Tripep Ab | Hepatitis C virus codon optimized non-structural NS3/4A fusion gene |
EP1195381A1 (en) * | 2000-09-28 | 2002-04-10 | Immusystems GmbH | Hepatitis c virus epitopes specific for cd4+ t-cell lymphocytes |
SK13142003A3 (en) | 2001-04-24 | 2004-11-03 | Innogenetics Nv | Core-glycosylated HCV envelope proteins |
AU2002311897A1 (en) * | 2001-05-09 | 2002-11-18 | Third Wave Technologies, Inc. | Nucleic acid detection in pooled samples |
US7196183B2 (en) | 2001-08-31 | 2007-03-27 | Innogenetics N.V. | Hepatitis C virus genotype, and its use as prophylactic, therapeutic and diagnostic agent |
US20030100467A1 (en) * | 2001-09-12 | 2003-05-29 | Wolfgang Aehle | Binding phenol oxidizing enzyme-peptide complexes |
AR045702A1 (en) * | 2001-10-03 | 2005-11-09 | Chiron Corp | COMPOSITIONS OF ASSISTANTS. |
US7332269B2 (en) * | 2001-11-11 | 2008-02-19 | Ortho-Clinical Diagnostics, Inc. | HCV core protein sequences |
WO2003073097A2 (en) * | 2002-02-28 | 2003-09-04 | Intercell Ag | Methods for isolating ligands e.g. t cell epitopes |
PT1490383E (en) * | 2002-03-11 | 2009-05-25 | Lab 21 Ltd | Methods and compositions for identifying and characterizing hepatitis c |
US7201904B2 (en) * | 2002-05-16 | 2007-04-10 | The General Hospital Corporation | Epitopes of hepatitis C virus |
FR2839722A1 (en) | 2002-05-17 | 2003-11-21 | Bio Merieux | Combination of peptides, useful for treatment, prevention or diagnosis of hepatitis C infection |
AU2003254585A1 (en) | 2002-07-24 | 2004-02-16 | Intercell Ag | Antigens encoded by alternative reading frame from pathogenic viruses |
AU2003273296B2 (en) | 2002-09-09 | 2009-11-26 | Grifols Worldwide Operations Limited | HCV assay |
EP1537418A2 (en) | 2002-09-13 | 2005-06-08 | Intercell AG | Method for isolating hepatitis c virus peptides |
EP2290082A1 (en) | 2003-03-04 | 2011-03-02 | Intercell AG | Streptococcus pyogenes antigens |
CN100355453C (en) * | 2003-03-24 | 2007-12-19 | 英特塞尔股份公司 | Improved vaccines |
AU2004224746B2 (en) | 2003-03-24 | 2009-04-23 | Valneva Austria Gmbh | Improved vaccines |
CN1774447B (en) | 2003-04-15 | 2011-04-06 | 英特塞尔股份公司 | S. pneumoniae antigens |
US7731967B2 (en) | 2003-04-30 | 2010-06-08 | Novartis Vaccines And Diagnostics, Inc. | Compositions for inducing immune responses |
EP2275131A3 (en) | 2003-07-11 | 2012-01-25 | Intercell AG | HCV Vaccines |
US20050202036A1 (en) * | 2003-07-22 | 2005-09-15 | Branch Andrea D. | Alternate reading frame polypeptides drived from hepatitis C and methods of their use |
US8124747B2 (en) | 2003-08-29 | 2012-02-28 | Innogenetics | HCV clade and prototype sequences thereof |
FR2859909B1 (en) | 2003-09-22 | 2007-09-07 | Biomerieux Sa | PROCESS FOR THE PREPARATION OF BIORESORBABLE MICROPARTICLES, MICROPARTICLES OBTAINED AND USE |
WO2005118621A2 (en) * | 2004-04-16 | 2005-12-15 | Genentech, Inc. | Omi pdz modulators |
US7871625B2 (en) * | 2004-08-27 | 2011-01-18 | Novartis Vaccines And Diagnostics, Inc. | HCV multiple epitope fusion antigens with modified proteolytic cleavage sites and uses thereof |
JP4897792B2 (en) | 2005-04-20 | 2012-03-14 | ビロメッド カンパニー, リミテッド | Compositions and methods for separation of fusion proteins |
US7968697B2 (en) * | 2005-05-25 | 2011-06-28 | Chrontech Pharma Ab | Hepatitis C virus non-structural NS3/4A fusion gene |
EP2061888A2 (en) | 2006-08-25 | 2009-05-27 | Novartis AG | Hcv fusion polypeptides |
JP4975600B2 (en) * | 2007-03-16 | 2012-07-11 | シスメックス株式会社 | Reagent kit for HCV antibody measurement and HCV antibody measurement method |
EP2185195A2 (en) | 2007-08-16 | 2010-05-19 | Tripep Ab | Immunogen platform |
ES2664753T3 (en) | 2007-12-07 | 2018-04-23 | Glaxosmithkline Biologicals Sa | Immune response induction compositions |
WO2009130588A2 (en) * | 2008-04-22 | 2009-10-29 | Tripep Ab | Immunogen platform |
US20100104555A1 (en) * | 2008-10-24 | 2010-04-29 | The Scripps Research Institute | HCV neutralizing epitopes |
CN103781470A (en) | 2011-07-06 | 2014-05-07 | 诺华股份有限公司 | Oil-in-water emulsions that contain nucleic acids |
JP6120839B2 (en) | 2011-07-06 | 2017-04-26 | ノバルティス アーゲー | Cationic oil-in-water emulsion |
FR2984328B1 (en) | 2011-12-20 | 2016-12-30 | Bio-Rad Innovations | METHOD FOR DETECTING HEPATITIS C VIRUS INFECTION |
WO2013150450A1 (en) * | 2012-04-02 | 2013-10-10 | Universidade Do Porto | Hcv homolog fragments, cell-lines and applications thereof |
BR112015023239A8 (en) | 2013-03-14 | 2018-04-17 | Abbott Lab | hcv antibody-antigen combination assay and methods and compositions for use thereof |
WO2014143342A1 (en) | 2013-03-14 | 2014-09-18 | Abbott Laboratories | Hcv ns3 recombinant antigens and mutants thereof for improved antibody detection |
CA2906417C (en) | 2013-03-14 | 2022-06-21 | Robert Ziemann | Hcv core lipid binding domain monoclonal antibodies |
US10267803B2 (en) | 2015-03-27 | 2019-04-23 | Ortho-Clinical Diagnostics, Inc. | HCV NS4A/modified NS3 polypeptides and uses thereof |
CN111153963B (en) * | 2020-01-19 | 2021-08-10 | 华南理工大学 | Anti-inflammatory pentapeptide, extraction and separation method thereof and application of anti-inflammatory pentapeptide in memory improvement |
Family Cites Families (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4861588A (en) * | 1985-02-05 | 1989-08-29 | New York Blood Center, Inc. | Pre-S gene coded peptide hepatitis B immunogens, vaccines, diagnostics, and synthetic lipid vesicle carriers |
YU48038B (en) | 1987-11-18 | 1996-10-18 | Chiron Corp. | PROCEDURE FOR DIAGNOSIS OF NO-A, NO-V HEPATITIS |
US5350671A (en) * | 1987-11-18 | 1994-09-27 | Chiron Corporation | HCV immunoassays employing C domain antigens |
CN1074422C (en) * | 1987-11-18 | 2001-11-07 | 希龙股份有限公司 | Nanbv diagnostics and vaccines |
US5312737A (en) | 1988-03-11 | 1994-05-17 | Abbott Laboratories | CKS method of HCV protein synthesis |
AU650038B2 (en) | 1988-03-11 | 1994-06-09 | Abbott Laboratories | CKS method of protein synthesis |
HUT54896A (en) * | 1989-03-17 | 1991-04-29 | Chiron Corp | Process for producing aquous diagnosticum and vaccine of nanbv |
EP0416725A3 (en) | 1989-07-14 | 1991-03-20 | Chugai Seiyaku Kabushiki Kaisha | Blood-borne non-a, non-b hepatitis specific protein, dna encoding it, and process for its production |
JP2818761B2 (en) | 1989-09-14 | 1998-10-30 | 財団法人化学及血清療法研究所 | Nucleic acid fragment encoding non-A non-B hepatitis virus antigen and use thereof |
US5372928A (en) | 1989-09-15 | 1994-12-13 | Chiron Corporation | Hepatitis C virus isolates |
CA2065287C (en) * | 1989-09-15 | 1999-12-21 | Tatsuo Miyamura | New hcv isolates |
CH684594A5 (en) * | 1989-12-18 | 1994-10-31 | Wellcome Found | viral agent. |
JPH03190898A (en) | 1989-12-21 | 1991-08-20 | Shima Kenkyusho:Kk | Synthetic polypeptide and reagent for hcv antibody analysis using same polypeptide |
CA2032907C (en) * | 1989-12-22 | 2002-05-14 | Richard R. Lesniewski | Hepatitis c assay |
EP0435229A1 (en) | 1989-12-27 | 1991-07-03 | Sanwa Kagaku Kenkyusho Co., Ltd. | DNA of non-A, non-B hepatitis virus gene, its clone and use thereof |
US5106726A (en) * | 1990-02-16 | 1992-04-21 | United Biomedical, Inc. | Synthetic peptides specific for the detection of antibodies to HCV |
KR940000755B1 (en) * | 1990-02-16 | 1994-01-29 | 유나이티드 바이오메디칼 인코오포레이티드 | Synthetic peptides specific for the detection of antibodies to hcv |
EP0527788B1 (en) | 1990-04-04 | 2004-06-30 | Chiron Corporation | Hepatitis c virus protease |
US5443965A (en) * | 1990-04-06 | 1995-08-22 | Genelabs Incorporated | Hepatitis C virus epitopes |
JPH044880A (en) | 1990-04-20 | 1992-01-09 | Terumasa Arima | Dna coding hepatitis non-a and non-b antigen and polypeptide |
JP3268502B2 (en) | 1990-06-12 | 2002-03-25 | 徹雄 中村 | Non-A non-B hepatitis virus-related polynucleotide, polypeptide |
JPH0446196A (en) | 1990-06-13 | 1992-02-17 | Kuraray Co Ltd | Antigen protein and dna fragment to code the same protein |
EP0933426A1 (en) | 1990-06-25 | 1999-08-04 | The Research Foundation for Microbial Diseases of Osaka University | Non-a, non-b hepatitis virus genomic cdna fragments and antigen polypeptides |
FI913068A (en) | 1990-06-25 | 1991-12-26 | Univ Osaka Res Found | NON-A-, NON-B-HEPATITISVIRUS PARTICLAR. |
EP0468657A3 (en) | 1990-07-09 | 1992-02-05 | Tonen Corporation | Non-a non b hepatitis-specific antigen and its use in hepatitus diagnosis |
JPH04126086A (en) | 1990-07-12 | 1992-04-27 | Yamanouchi Pharmaceut Co Ltd | Antigen polypeptide against non-a and non-b type hepatitis virus, polynucleotide coding same polypeptide and diagnosis of non-a and non-b type hepatitis using them |
CA2047792C (en) | 1990-07-26 | 2002-07-02 | Chang Y. Wang | Synthetic peptides specific for the detection of antibodies to hcv, diagnosis of hcv infection and prevention thereof as vaccines |
WO1992002642A1 (en) | 1990-08-10 | 1992-02-20 | Chiron Corporation | Nanbv diagnostics: polynucleotides useful for screening for hepatitis c virus |
CA2049679C (en) | 1990-08-24 | 2005-06-21 | Sushil G. Devare | Hepatitis c assay utilizing recombinant antigens |
CA2090335A1 (en) | 1990-08-25 | 1992-02-26 | Suzanne Zebedee | Non-a, non-b hepatitis virus antigen, diagnostic methods and vaccines |
JP3055793B2 (en) | 1990-09-07 | 2000-06-26 | 財団法人化学及血清療法研究所 | Non-A non-B hepatitis virus fusion peptide and method for producing the same |
JPH04144686A (en) | 1990-10-04 | 1992-05-19 | Kunitada Shimotoono | Structural protein gene, recombinant vector, escherichia coli transformed therewith, polypeptide and its production |
JPH04159298A (en) | 1990-10-19 | 1992-06-02 | Olympus Optical Co Ltd | Hcv peptide |
DE59109221D1 (en) | 1990-11-03 | 2001-11-15 | Dade Behring Marburg Gmbh | HCV-specific peptides, agents therefor and their use |
EP0485209A1 (en) | 1990-11-08 | 1992-05-13 | Immuno Japan Inc. | Non A, non B hepatitis virus related antigen, antibody detection systems, polynucleotides and polypeptides |
JPH04179482A (en) | 1990-11-11 | 1992-06-26 | Kunitada Shimotoono | Gene derived from hepatitis c virus |
JPH04187090A (en) | 1990-11-22 | 1992-07-03 | Toshio Shikata | Dna encoding hepatitis antigen of non-a non-b type and polypeptide |
KR920703640A (en) | 1990-11-29 | 1992-12-18 | 테루카츄 아리마 | Non-A Hepatitis B Virus Antigen Protein |
ATE149522T1 (en) | 1990-12-14 | 1997-03-15 | Innogenetics Nv | SYNTHETIC ANTIGENS FOR DETECTING ANTIBODIES AGAINST HEPATITIS C VIRUS |
KR930703361A (en) | 1991-01-31 | 1993-11-29 | 찰스 엠. 브룩 | Monoclonal Antibodies to Putative Hepatitis C Virus (HCV) Outer Membrane Regions and Methods of Use thereof |
JP3244284B2 (en) | 1991-02-14 | 2002-01-07 | 武田薬品工業株式会社 | Method for measuring hepatitis C virus-related antibodies and antigens |
US5574132A (en) | 1991-04-05 | 1996-11-12 | Biochem Immunosystems Inc. | Peptides and mixtures thereof for detecting antibodies to hepatitis C virus (HCV) |
JPH0568562A (en) | 1991-05-30 | 1993-03-23 | Sanwa Kagaku Kenkyusho Co Ltd | Cdna of human hepatitis c virus, its clone and their use |
JP3055964B2 (en) | 1991-05-31 | 2000-06-26 | 株式会社トクヤマ | HCV antigen-active polypeptide, method for producing polypeptide, transformed Escherichia coli, and method for detecting anti-HCV antibody |
FR2677372B1 (en) | 1991-06-06 | 1994-11-10 | Pasteur Institut | NUCLEOTIDE AND PEPTIDE SEQUENCES OF A HEPATITIS C VIRUS ISOLATE, DIAGNOSTIC AND THERAPEUTIC APPLICATIONS. |
GB2272443B (en) | 1991-06-10 | 1995-10-25 | Lucky Ltd | Nucleotide and amino acid sequences of Korean hepatitis C virus |
CA2070952A1 (en) | 1991-06-11 | 1992-12-12 | Makoto Seki | Gene of hepatitis c virus or fragment thereof, polypeptide encoded by the same |
CA2087974A1 (en) | 1991-06-13 | 1992-12-14 | David C. Leahy | Immunoassay for non-a non-b hepatitis |
JP3103180B2 (en) | 1992-01-30 | 2000-10-23 | 昭和電工株式会社 | Soft synthetic resin sheet |
JP3190898B2 (en) | 1998-11-09 | 2001-07-23 | 米沢日本電気株式会社 | Notebook personal computer |
-
1992
- 1992-06-24 RU RU93058563A patent/RU2148587C1/en active
- 1992-06-24 WO PCT/US1992/005388 patent/WO1993000365A2/en active IP Right Grant
- 1992-06-24 AT AT92914835T patent/ATE229543T1/en active
- 1992-06-24 KR KR1019930704022A patent/KR0185426B1/en not_active IP Right Cessation
- 1992-06-24 JP JP50167193A patent/JP3516681B2/en not_active Expired - Lifetime
- 1992-06-24 HU HU9303703A patent/HU227547B1/en unknown
- 1992-06-24 RO RO93-01778A patent/RO117329B1/en unknown
- 1992-06-24 ES ES92914835T patent/ES2188583T3/en not_active Expired - Lifetime
- 1992-06-24 UA UA93004481A patent/UA40572C2/en unknown
- 1992-06-24 DE DE69232871T patent/DE69232871T2/en not_active Expired - Lifetime
- 1992-06-24 CA CA002110058A patent/CA2110058C/en not_active Expired - Lifetime
- 1992-06-24 EP EP92914835A patent/EP0591431B1/en not_active Expired - Lifetime
-
1993
- 1993-12-10 NO NO934542A patent/NO309528B1/en not_active IP Right Cessation
- 1993-12-22 FI FI935808A patent/FI110099B/en not_active IP Right Cessation
- 1993-12-23 BG BG98332A patent/BG61843B1/en unknown
-
1995
- 1995-03-14 US US08/403,590 patent/US6346375B1/en not_active Expired - Lifetime
- 1995-05-18 US US08/444,818 patent/US6150087A/en not_active Expired - Lifetime
-
1999
- 1999-11-25 JP JP33516799A patent/JP3514680B2/en not_active Expired - Lifetime
-
2002
- 2002-09-11 FI FI20021626A patent/FI111645B/en not_active IP Right Cessation
-
2003
- 2003-02-28 JP JP2003054819A patent/JP3514751B2/en not_active Expired - Lifetime
- 2003-11-14 JP JP2003385979A patent/JP3619827B2/en not_active Expired - Lifetime
-
2004
- 2004-09-27 JP JP2004280446A patent/JP3926817B2/en not_active Expired - Lifetime
-
2006
- 2006-11-21 JP JP2006314881A patent/JP4456596B2/en not_active Expired - Lifetime
- 2006-11-21 JP JP2006314880A patent/JP4456595B2/en not_active Expired - Lifetime
-
2007
- 2007-08-21 JP JP2007215324A patent/JP2008001716A/en not_active Withdrawn
-
2008
- 2008-10-20 JP JP2008270386A patent/JP2009084285A/en not_active Withdrawn
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI20021626A (en) | Immunoassay reagent and method for the detection of hepatitis C virus (HCV) antibodies | |
UA41266C2 (en) | COMBINATION OF HEPATITIS C VIRUS (HCV) EPITOPE SEQUENCES, METHOD OF DETECTION OF ANTIBODIES TO HEPATITIS VIRUS (HCV), KIT FOR ANALYTES ANALYTES ANALYSIS ANALYSIS | |
NO870412L (en) | PEPTIDES. | |
UA39944C2 (en) | METHOD FOR DETERMINATION OF EARLY SEROCONVERSION IN MAMMAL-TO-MACHINE TO HEPATITIS C VIRUS AND KIT FOR USE IN THE METHOD | |
DK0489968T3 (en) | Synthetic antigens for detection of antibodies against hepatitis C virus | |
DE69131707D1 (en) | Detection of hepatitis C using recombinant antigens | |
ATE191792T1 (en) | METHOD FOR DETECTING HEPATITIS C | |
DE3579856D1 (en) | IMMUNULOGICAL TEST FOR DETERMINING COMMON, DETERMINING HEPATITIS B ANTIBODIES. | |
CA2116026A1 (en) | Hepatitis c assay utilizing recombinant antigens to c-100 region |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Transfer of assignment of patent |
Owner name: NOVARTIS VACCINES AND DIAGNOSTICS, INC. Free format text: NOVARTIS VACCINES AND DIAGNOSTICS, INC. |
|
MA | Patent expired |